October is a month dedicated to raising breast cancer awareness. At Color, we believe in turning awareness into action, especially as we navigate the COVID-19 crisis.
Breast cancer survival rates increase from 25% to 98% when caught early.
Cancer Care During COVID-19
COVID-19 has interrupted traditional preventative measures.
This summer, weekly cancer screening volumes for breast, colon and cervical cancer were as much as 36% lower than their pre-COVID-19 levels.6
COVID-19 could reverse falling cancer mortality rates.
Over the next 10 years, there could be up to 10,000 additional deaths from breast and colorectal cancer alone, due to missed screenings during the pandemic.7 Read more here on how to stay current with your screenings during the pandemic.
Unlike recreational genetic tests, Color’s precision health program offers clinical results, genetic counseling services, and actionable next steps.*
*The Color test does not diagnose cardiovascular disease. It is a physician-ordered test that can provide information about your risk for common hereditary heart conditions. Knowing your genetic risk can help you and your doctor develop a personalized screening and prevention plan.
NIH Awards Color $4.6 million to provide Genetic Counseling for million-person study.
Tung N, Battelli C, Allen B, et al. Frequency of mutations in individuals with breast cancer referred for BRCA1 and BRCA2 testing using next-generation sequencing with a 25-gene panel. Cancer. January 2015;121(1):25-33.
Pal T, Permuth-Wey J, Betts JA, et al. BRCA1 and BRCA2 mutations account for a large proportion of ovarian carcinoma cases. Cancer. December 2005;104(12):2807-16.
Claus EB, Risch N, Thompson WD, et al. The calculation of breast cancer risk for women with a first degree family history of ovarian cancer. Breast Cancer Res Treat. November 1993;28(2):115-20.
Risch HA, McLaughlin JR, Cole DE, et al. Prevalence and penetrance of germline BRCA1 and BRCA2 mutations in a population series of 649 women with ovarian cancer. Am J Hum Genet. March 2001;68(3):700-10.
SEER Stat Fact Sheets: Breast Cancer. Published November 2013. National Cancer Institute.
Mast C. and Munoz del Rio A. Delayed Cancer Screenings—A Second Look. Epic Health Research Network website. July 17, 2020. Accessed October 5, 2020.
Sharpless NE. COVID-19 and cancer. Science. June 2020;368(6497):1290.